Literature DB >> 20683338

Long-term reduction in aortic stiffness: a 5.3-year follow-up in routine clinical practice.

Hafid Ait-Oufella1, Cédric Collin, Erwan Bozec, Brigritte Laloux, Kim-Thanh Ong, Carole Dufouil, Pierre Boutouyrie, Stéphane Laurent.   

Abstract

BACKGROUND: Whether a direct blood pressure-independent reduction in aortic stiffness can occur after several years of antihypertensive treatment has never been unequivocally demonstrated.
METHOD: In this observational study, performed under conditions of routine clinical practice, we included 97 patients (age 63 ± 11 years) with treated essential hypertension who attended the outpatient hypertension clinic of a university hospital, had a significant blood pressure (BP) lowering under treatment before the first measurement of aortic stiffness, and had at least one additional measurement of aortic stiffness during follow-up. Aortic stiffness and carotid pulse pressure (PP) were determined through carotid-femoral pulse wave velocity (PWV) and applanation tonometry, respectively.
RESULTS: A linear mixed model showed that the reduction in PWV (from 14.2 ± 4.2 to 11.0 ± 2.4 m/s; P < 0.0001) over a long follow-up (mean delay 5.3 ± 1.3 years) was associated with a significant reduction in central SBP (from 132 ± 22 to 122 ± 16 mmHg; P < 0.0001) and central PP (from 59 ± 22 to 54 ± 14; P < 0.001), contrasting with a smaller change in brachial SBP (from 132 ± 17 to 129 ± 16 mmHg; P < 0.02) and no change in brachial PP. In multivariate analysis, the decrease in PWV (-0.70 ± 0.07 m/s per year; P < 0.0001) was only slightly explained by the reduction in mean blood pressure. By contrast, the decrease in central PP (-0.83 ± 0.41 mmHg per year; P = 0.043) was largely explained by the reduction in PWV.
CONCLUSION: These results indicate that a large and sustained decrease in aortic stiffness can be obtained in treated hypertensive patients under conditions of routine clinical practice. These changes likely represent a delayed response to the long-term normalization of BP and cardiovascular risk factors, through arterial remodeling.

Entities:  

Mesh:

Substances:

Year:  2010        PMID: 20683338     DOI: 10.1097/HJH.0b013e32833da2b2

Source DB:  PubMed          Journal:  J Hypertens        ISSN: 0263-6352            Impact factor:   4.844


  20 in total

Review 1.  Arterial aging: a review of the pathophysiology and potential for pharmacological intervention.

Authors:  Michael F O'Rourke; Audrey Adji; Mayooran Namasivayam; Jonathan Mok
Journal:  Drugs Aging       Date:  2011-10-01       Impact factor: 3.923

Review 2.  Future Treatment of Hypertension: Shifting the Focus from Blood Pressure Lowering to Arterial Stiffness Modulation?

Authors:  Henry Fok; J Kennedy Cruickshank
Journal:  Curr Hypertens Rep       Date:  2015-08       Impact factor: 5.369

Review 3.  Pharmacological modulation of arterial stiffness.

Authors:  Pierre Boutouyrie; Patrick Lacolley; Marie Briet; Véronique Regnault; Alice Stanton; Stéphane Laurent; Azra Mahmud
Journal:  Drugs       Date:  2011-09-10       Impact factor: 9.546

4.  Ten-year longitudinal change in aortic stiffness assessed by cardiac MRI in the second half of the human lifespan: the multi-ethnic study of atherosclerosis.

Authors:  Yoshiaki Ohyama; Gisela Teixido-Tura; Bharath Ambale-Venkatesh; Chikara Noda; Atul R Chugh; Chia-Ying Liu; Alban Redheuil; R Brandon Stacey; Harry Dietz; Antoinette S Gomes; Martin R Prince; Arturo Evangelista; Colin O Wu; W Gregory Hundley; David A Bluemke; Joao A C Lima
Journal:  Eur Heart J Cardiovasc Imaging       Date:  2016-01-12       Impact factor: 6.875

Review 5.  Arterial (Aortic) Stiffness in Patients with Resistant Hypertension: from Assessment to Treatment.

Authors:  James E Sharman; Pierre Boutouyrie; Stéphane Laurent
Journal:  Curr Hypertens Rep       Date:  2017-01       Impact factor: 5.369

Review 6.  Treatment of arterial remodeling in essential hypertension.

Authors:  Marie Briet; Ernesto L Schiffrin
Journal:  Curr Hypertens Rep       Date:  2013-02       Impact factor: 5.369

Review 7.  Hypertensive Mediated Organ Damage and Hypertension Management. How to Assess Beneficial Effects of Antihypertensive Treatments?

Authors:  Daniel Piskorz
Journal:  High Blood Press Cardiovasc Prev       Date:  2020-01-23

8.  Pulse wave velocity progression over a medium-term follow-up in hypertensives: Focus on uric acid.

Authors:  Alessandro Maloberti; Paola Rebora; Anita Andreano; Paola Vallerio; Benedetta De Chiara; Stefano Signorini; Marco Casati; Silvia Besana; Michele Bombelli; Guido Grassi; Maria Grazia Valsecchi; Cristina Giannattasio
Journal:  J Clin Hypertens (Greenwich)       Date:  2019-06-21       Impact factor: 3.738

9.  Arterial stiffness in elderly patients with normotension and hypertension in Brazil.

Authors:  Guilherme Silva de Mendonça; Denis Fabiano de Souza; Ana Cláudia de Alvarenga Cunha Brunelli; Cristina Ila de Oliveira Peres; Ercilhana Gonçalves Batista Freitas; Gabriela Nolasco Lacerda; Michelle Caixeta Dorneles; Aldo José Peixoto; Sebastião Rodrigues Ferreira-Filho
Journal:  J Clin Hypertens (Greenwich)       Date:  2018-07-24       Impact factor: 3.738

10.  Abnormal Pulsatile Hemodynamics in Hypertensive Patients With Normalized 24-Hour Ambulatory Blood Pressure by Combination Therapy of Three or More Antihypertensive Agents.

Authors:  Dai-Yin Lu; Li-Kai You; Shih-Hsien Sung; Hao-Min Cheng; Shing-Jong Lin; Fu-Tien Chiang; Chen-Huan Chen; Wen-Chung Yu
Journal:  J Clin Hypertens (Greenwich)       Date:  2015-12-10       Impact factor: 3.738

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.